Chapter 4: CKD treatment in cancer survivors, from Clinical Practice Guidelines for the Management of Kidney Injury During Anticancer Drug Therapy 2022

被引：1

作者：

Ishikura, Kenji ^{[1
]}

Omae, Kenji ^{[2
]}

Sasaki, Sho ^{[3
]}

Shibagaki, Yugo ^{[4
]}

Ichioka, Satoko ^{[5
]}

Okuda, Yusuke ^{[1
]}

Koitabashi, Kenichiro ^{[6
]}

Suyama, Koichi ^{[7
]}

Mizukami, Takuro ^{[8
]}

Kondoh, Chihiro ^{[9
]}

Hirata, Sumio ^{[10
]}

Matsubara, Takeshi ^{[11
]}

Hoshino, Junichi ^{[12
]}

Yanagita, Motoko ^{[11
,13
]}

机构：

[1] Kitasato Univ, Sch Med, Dept Pediat, Kawasaki, Japan

[2] Fukushima Med Univ Hosp, Dept Innovat Res & Educ Clinicians & Trainees, Fukushima, Japan

[3] Kyoto Univ Hosp, Sect Educ Clin Res, Kyoto, Japan

[4] St Marianna Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Kawasaki, Kanagawa, Japan

[5] Shiga Univ Med Sci, Dept Pediat, Otsu, Shiga, Japan

[6] Inagi Municipal Hosp, Div Nephrol, Tokyo, Japan

[7] Toranomon Gen Hosp, Dept Med Oncol, Tokyo, Japan

[8] NTT Med Ctr Tokyo, Dept Med Oncol, Tokyo, Japan

[9] Natl Canc Ctr Hosp East, Dept Med Oncol, Kashiwa, Japan

[10] I&H Co Ltd, Dept Acad Educ, Ashiya, Japan

[11] Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto, Japan

[12] Tokyo Womens Med Univ, Dept Nephrol, Tokyo, Japan

[13] Kyoto Univ, Inst Adv Study Human Biol ASHBi, Kyoto, Japan

来源：

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 28卷 / 10期

关键词：

Chronic kidney disease; Cancer survivors; Epidemiology; Treatment; Renal replacement therapy; TRANSPLANT RECIPIENTS; RISK-FACTORS; DISEASE; NEPHROTOXICITY; HEMODIALYSIS; CHILDREN; OUTCOMES; ADULT;

D O I：

10.1007/s10147-023-02375-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Chronic kidney disease (CKD) is one of the most disabling disorders with significant comorbidity and mortality. Incidence and prevalence of CKD in cancer survivors are remarkably high in both adults and pediatric patients. The reasons for this high incidence/prevalence are multifold but kidney damage by cancer itself and cancer treatment (pharmacotherapy/surgery/radiation) are the main reasons. Since cancer survivors commonly have significant comorbidities, risk of cancer recurrence, limited physical function or life expectancy, special attentions should be paid when considering the treatment of CKD and its complications. Especially, shared decision-making should be considered when selecting the renal replacement therapies with as much information/facts/evidence as possible.

引用

页码：1333 / 1342

页数：10

共 69 条

[1] AKIZAWA T, 1994, NEPHROL DIAL TRANSPL, V9, P162
[2] [Anonymous], 2017, N Engl J Med, V377, P2506, DOI 10.1056/NEJMx170008
[3] ANONYMOUS, 2013, NEPHROL DIAL TRANSPL, V28, P1, DOI DOI 10.1093/NDT/GFT218
[4] Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study
Arnold, Melina
Rutherford, Mark J.
Bardot, Aude
Ferlay, Jacques
Andersson, Therese M-L
Myklebust, Tor Age
Tervonen, Hanna
Thursfield, Vicky
Ransom, David
Shack, Lorraine
Woods, Ryan R.
Turner, Donna
Leonfellner, Suzanne
Ryan, Susan
Saint-Jacques, Nathalie
De, Prithwish
McClure, Carol
Ramanakumar, Agnihotram V.
Stuart-Panko, Heather
Engholm, Gerda
Walsh, Paul M.
Jackson, Christopher
Vernon, Sally
Morgan, Eileen
Gavin, Anna
Morrison, David S.
Huws, Dyfed W.
Porter, Geoff
Butler, John
Bryant, Heather
Currow, David C.
Hiom, Sara
Parkin, D. Max
Sasieni, Peter
Lambert, Paul C.
Moller, Bjorn
Soerjomataram, Isabelle
Bray, Freddie
[J]. LANCET ONCOLOGY, 2019, 20 (11) : 1493 - 1505
[5] Changes in cancer incidence and outcomes among kidney transplant recipients in the United States over a thirty-year period
Blosser, Christopher D.
Haber, Gregory
Engels, Eric A.
[J]. KIDNEY INTERNATIONAL, 2021, 99 (06) : 1430 - 1438
[6] Anticipating the "Silver Tsunami": Prevalence Trajectories and Comorbidity Burden among Older Cancer Survivors in the United States
Bluethmann, Shirley M.
Mariotto, Angela B.
Rowland, Julia H.
[J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (07) : 1029 - 1036
[7] Bölling T, 2010, ANTICANCER RES, V30, P227
[8] The Risk of Tumour Recurrence in Patients Undergoing Renal Transplantation for End-stage Renal Disease after Previous Treatment for a Urological Cancer: A Systematic Review
Boissier, Romain
Hevia, Vital
Bruins, Harman Max
Budde, Klemens
Figueiredo, Arnaldo
Lledo-Garcia, Enrique
Olsburgh, Jonathon
Regele, Heinz
Taylor, Claire Fraser
Zakri, Rhana Hassan
Yuan, Cathy Yuhong
Breda, Alberto
[J]. EUROPEAN UROLOGY, 2018, 73 (01) : 94 - 108
[9] Overall and Cause-Specific Mortality in Transplant Recipients with a Pretransplantation Cancer History
Brattstrom, Christina
Granath, Fredrik
Edgren, Gustaf
Smedby, Karin E.
Wilczek, Henryk E.
[J]. TRANSPLANTATION, 2013, 96 (03) : 297 - 305
[10] Cancer Incidence Among US Medicare ESRD Patients Receiving Hemodialysis, 1996-2009
Butler, Anne M.
Olshan, Andrew F.
Kshirsagar, Abhijit V.
Edwards, Jessie K.
Nielsen, Matthew E.
Wheeler, Stephanie B.
Brookhart, M. Alan
[J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 65 (05) : 763 - 772

← 1 2 3 4 5 6 7 →